BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meikle CKS, Creeden JF, McCullumsmith C, Worth RG. SSRIs: Applications in inflammatory lung disease and implications for COVID-19. Neuropsychopharmacol Rep 2021;41:325-35. [PMID: 34254465 DOI: 10.1002/npr2.12194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Menter DG, Afshar-Kharghan V, Shen JP, Martch SL, Maitra A, Kopetz S, Honn KV, Sood AK. Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective. Cancer Metastasis Rev 2022. [PMID: 35022962 DOI: 10.1007/s10555-022-10019-5] [Reference Citation Analysis]
2 Aree T. Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex. Pharmaceuticals 2022;15:98. [DOI: 10.3390/ph15010098] [Reference Citation Analysis]
3 Battaglia DM, Sanchez-pino MD, Nichols CD, Foster TP. Herpes Simplex Virus-1 Induced Serotonin-Associated Metabolic Pathways Correlate With Severity of Virus- and Inflammation-Associated Ocular Disease. Front Microbiol 2022;13:859866. [DOI: 10.3389/fmicb.2022.859866] [Reference Citation Analysis]
4 Aree T. Advancing insights on β-cyclodextrin inclusion complexes with SSRIs through lens of X-ray diffraction and DFT calculation. Int J Pharm 2021;609:121113. [PMID: 34543619 DOI: 10.1016/j.ijpharm.2021.121113] [Reference Citation Analysis]
5 Le Corre P, Loas G. Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection. Front Pharmacol 2022;13:849095. [DOI: 10.3389/fphar.2022.849095] [Reference Citation Analysis]
6 Meikle CKS, Creeden JF, McCullumsmith C, Worth RG. SSRIs: Applications in inflammatory lung disease and implications for COVID-19. Neuropsychopharmacol Rep 2021;41:325-35. [PMID: 34254465 DOI: 10.1002/npr2.12194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]